Old Web
English
Sign In
Acemap
>
Paper
>
RGC-32 as a potential marker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
RGC-32 as a potential marker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
2015
Horea Rus
Adam M. Kruszewski
Cornelia Cudrici
Vingh Nguyen
Walter Royal
Christopher T. Bever
Violeta Rus
Keywords:
Multiple sclerosis
Glatiramer acetate
Medicine
Oncology
Internal medicine
response to treatment
Physical therapy
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]